Asia-pacific Medical Enzymes Market Forecast 2022-2030

The Asia-Pacific medical enzymes market is set to develop with a CAGR of 7.49% across the estimated period of 2022 to 2030. Some of the key aspects fueling the market's growth include poor dietary habits prevalent in developing countries, rapid industrialization, increasing weight and eating routine concerns, and the rise in research and development expenditure.

MARKET INSIGHTS

The Asia-Pacific medical enzymes market growth evaluation covers the analysis of Thailand, South Korea, China, Indonesia, India, Vietnam, Japan, Australia & New Zealand, and Rest of Asia-Pacific. India is one of the largest providers of drugs globally. Moreover, the country is also a key supplier of low-cost vaccines, primarily owing to their high quality and affordability. As per the data issued by the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers, India is the third-largest market for APIs across the world, as well.

Moreover, with the National Pharmaceutical Pricing Policy, essential medications are also available in India at reasonable prices. The low cost of production, in addition to increased research and development, further enhance the efficacy of pharmaceutical companies in the country. In this regard, according to the IBEF, India's drugs and pharma exports captured $5.78 billion from April 2021 to June 2021. As a result, these factors are anticipated to propel the medical enzymes market growth in the Asia-Pacific over the forecast years.

COMPETITIVE INSIGHTS

Well-established companies operating in the market include: Amano Enzyme, Advanced Enzyme Technologies, etc.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation cater to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 46209

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. INCREASED INVESTMENT IN HEALTHCARE RESEARCH AND FACILITIES
- 3.1.2. WIDENING APPLICATION IN MEDICAL INDUSTRY
- 3.1.3. GROWING PREVALENCE OF CHRONIC DISEASES AND RISING AGING POPULATION
3.2. KEY RESTRAINTS
- 3.2.1. HANDLING AND SAFETY OF ENZYMES
- 3.2.2. REGULATIONS FOR MEDICAL ENZYMES

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON MEDICAL ENZYMES MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
- 4.6.1. RESEARCH AND DEVELOPMENT
- 4.6.2. OPERATIONS
- 4.6.3. OUTBOUND LOGISTICS
4.7. KEY BUYING CRITERIA
- 4.7.1. COST
- 4.7.2. QUALITY
- 4.7.3. APPLICATION
4.8. REGULATORY FRAMEWORK

5. MARKET BY TYPE

5.1. HYDROLASE
- 5.1.1. HYALURONIDASE
- 5.1.2. LYSOZYMES
- 5.1.3. OTHER HYDROLASES ENZYMES
5.2. THROMBOLYTIC
- 5.2.1. STREPTOKINASE
- 5.2.2. UROKINASE
- 5.2.3. OTHER THROMBOLYTIC ENZYMES
5.3. DIGESTIVE ENZYME
- 5.3.1. LACTASE
- 5.3.2. L-ASPARAGINASE
- 5.3.3. OTHER DIGESTIVE ENZYMES
5.4. ENDONUCLEASE
- 5.4.1. BENZONASE
- 5.4.2. OTHER ENDONUCLEASES

6. MARKET BY APPLICATION

6.1. DISEASE TREATMENT
6.2. DIAGNOSTIC TOOLS
6.3. BIOMEDICAL RESEARCH
6.4. OTHER APPLICATIONS

7. GEOGRAPHICAL ANALYSIS

7.1. ASIA-PACIFIC
- 7.1.1. MARKET SIZE & ESTIMATES
- 7.1.2. KEY GROWTH ENABLERS
- 7.1.3. KEY CHALLENGES
- 7.1.4. KEY PLAYERS
- 7.1.5. COUNTRY ANALYSIS
  - 7.1.5.1. CHINA
  - 7.1.5.2. JAPAN
  - 7.1.5.3. INDIA
  - 7.1.5.4. SOUTH KOREA
  - 7.1.5.5. INDONESIA
  - 7.1.5.6. THAILAND
  - 7.1.5.7. VIETNAM
  - 7.1.5.8. AUSTRALIA & NEW ZEALAND
  - 7.1.5.9. REST OF ASIA-PACIFIC

8. COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIC DEVELOPMENTS
- 8.1.1. MERGERS & ACQUISITIONS
- 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 8.1.3. PARTNERSHIPS & AGREEMENTS
- 8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
- 8.2.1. ADVANCED ENZYMES
- 8.2.2. AMANO ENZYME
- 8.2.3. BASF
- 8.2.4. BBI SOLUTIONS
- 8.2.5. BRAIN
- 8.2.6. CODEXIS
- 8.2.7. CPC BIOTECH
- 8.2.8. DSM
- 8.2.9. DUPONT
- 8.2.10. NOVOZYMES
- 8.2.11. NOVUS
- 8.2.12. ROCHE
- 8.2.13. SANOFI
- 8.2.14. SEKISUI
- 8.2.15. THERMO FISHER SCIENTIFIC

Product Code: 46209

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - MEDICAL ENZYMES
TABLE 2: MEDICAL APPLICATION OF VARIOUS ENZYMES
TABLE 3: APPLICATIONS OF ENZYMES IN PHARMACEUTICALS INDUSTRY
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC, ENZYME HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: LEADING PLAYERS OPERATING IN ASIA-PACIFIC MEDICAL ENZYMES MARKET
TABLE 20: LIST OF MERGERS & ACQUISITIONS
TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 22: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 23: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: ASIA-PACIFIC MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
FIGURE 8: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY HYDROLASE ENZYME, IN 2021
FIGURE 10: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2030 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY THROMBOLYTIC ENZYME, IN 2021
FIGURE 15: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2030 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2030 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2030 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY DIGESTIVE ENZYME, IN 2021
FIGURE 20: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2030 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2030 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2030 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY ENDONUCLEASE, IN 2021
FIGURE 25: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2030 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2030 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 28: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2030 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2030 (IN $ MILLION)
FIGURE 30: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2030 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 33: CHINA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: JAPAN MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: INDIA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: SOUTH KOREA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: INDONESIA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: THAILAND MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 39: VIETNAM MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: AUSTRALIA & NEW ZEALAND MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 41: REST OF ASIA-PACIFIC MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)